STOCK TITAN

Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on November 29, 2022, at 2:40 p.m. ET. The event will be accessible through a live webcast on Alkermes’ investor page, with an archived version available for 14 days post-event. Alkermes is a global biopharmaceutical company focused on innovative medicines for neuroscience and oncology, with a diverse portfolio aimed at treating alcohol dependence, opioid dependence, schizophrenia, and bipolar disorder.

Positive
  • None.
Negative
  • None.

DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, Nov. 29, 2022 at 2:40 p.m. ET (7:40 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Sandy Coombs
Investor Relations
+1 781 609 6377

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference-301684223.html

SOURCE Alkermes plc

FAQ

When will Alkermes participate in the Evercore ISI HealthCONx Conference?

Alkermes will participate in the Evercore ISI HealthCONx Conference on November 29, 2022, at 2:40 p.m. ET.

How can I watch the Alkermes fireside chat live?

The live webcast of the Alkermes fireside chat can be accessed under the Investors tab on their website.

How long will the Alkermes conference webcast be available?

The recorded webcast of the Alkermes conference will be available for 14 days after the live event.

What is Alkermes' focus in the biopharmaceutical industry?

Alkermes focuses on developing innovative medicines for neuroscience and oncology, with products for alcohol and opioid dependence, schizophrenia, and bipolar disorder.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4